uniQure N.V. - Ordinary Shares (QURE) Social Stream
UNIQURE NV (QURE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering UNIQURE NV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 14 | $95 | $40 | $67.916 | $6.62 | 925.92% |
| 2021-12-10 | 14 | $95 | $40 | $68 | $6.62 | 927.19% |
| 2021-12-17 | 13 | $95 | $40 | $66.818 | $6.62 | 909.34% |
| 2022-03-01 | 13 | $95 | $40 | $66.363 | $6.62 | 902.46% |
| 2022-03-17 | 13 | $95 | $40 | $66.363 | $6.62 | 902.46% |
| 2022-03-29 | 13 | $95.001 | $40 | $66.363 | $6.62 | 902.46% |
| 2022-03-30 | 13 | $90 | $40 | $64.8 | $6.62 | 878.85% |
| 2022-04-07 | 12 | $90 | $40 | $64.8 | $6.62 | 878.85% |
| 2022-04-13 | 12 | $90 | $40 | $60.9 | $6.62 | 819.94% |
| 2022-05-02 | 12 | $90 | $40 | $59.4 | $6.62 | 797.28% |
| 2022-05-04 | 12 | $90 | $40 | $59 | $6.62 | 791.24% |
| 2022-05-05 | 12 | $90 | $37 | $56.1 | $6.62 | 747.43% |
| 2022-05-24 | 13 | $90 | $37 | $55.636 | $6.62 | 740.42% |
| 2022-07-20 | 12 | $90 | $34 | $56.3 | $6.62 | 750.45% |
| 2022-08-08 | 13 | $90 | $34 | $55.1 | $6.62 | 732.33% |
| 2022-08-10 | 13 | $90 | $24 | $50.727 | $6.62 | 666.27% |
| 2022-11-03 | 13 | $90 | $24 | $50.454 | $6.62 | 662.15% |
| 2022-11-23 | 13 | $90 | $24 | $52.818 | $6.62 | 697.85% |
| 2022-12-01 | 13 | $90 | $24 | $53 | $6.62 | 700.6% |
| 2023-01-17 | 13 | $90 | $24 | $53.181 | $6.62 | 703.34% |
| 2023-02-28 | 14 | $90 | $24 | $53.166 | $6.62 | 703.11% |
| 2023-03-08 | 14 | $90 | $24 | $52.916 | $6.62 | 699.34% |
| 2023-04-05 | 14 | $90 | $24 | $53.916 | $6.62 | 714.44% |
| 2023-05-09 | 13 | $90 | $24 | $53.454 | $6.62 | 707.46% |
| 2023-05-10 | 14 | $90 | $24 | $52.166 | $6.62 | 688.01% |
| 2023-05-16 | 14 | $90 | $24 | $52 | $6.62 | 685.5% |
| 2023-06-22 | 15 | $90 | $24 | $50.307 | $6.62 | 659.92% |
| 2023-06-23 | 15 | $90 | $14 | $47.615 | $6.62 | 619.26% |
| 2023-08-01 | 15 | $90 | $14 | $47.833 | $6.62 | 622.55% |
| 2023-08-03 | 15 | $57 | $14 | $40.75 | $6.62 | 515.56% |
| 2023-08-08 | 15 | $57 | $14 | $39.5 | $6.62 | 496.68% |
| 2023-11-07 | 13 | $57 | $14 | $34.818 | $6.62 | 425.95% |
| 2023-11-09 | 13 | $63 | $14 | $34.818 | $6.62 | 425.95% |
| 2023-12-20 | 13 | $63 | $14 | $34.909 | $6.62 | 427.33% |
The Trend in the Analyst Price Target
Over the past 21 months, QURE's average price target has gone down $29.89.
QURE reports an average of 285.38% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-08 | 13 | 90 | 24 | 54.090 | 21.270 | 154.3% |
| 2023-06-23 | 14 | 90 | 14 | 48.333 | 11.450 | 322.12% |
| 2023-06-23 | 14 | 90 | 14 | 46.692 | 11.450 | 307.79% |
| 2023-06-23 | 15 | 90 | 14 | 46.692 | 11.450 | 307.79% |
| 2023-11-07 | 13 | 57 | 14 | 34.818 | 6.885 | 405.71% |
QURE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.31 | 10 | 2 | 1 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 27 months, QURE's average broker recommendation rating improved by 0.29.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for QURE as an investment opportunity.
- UNIQURE NV's upside potential (average analyst target price relative to current price) is higher than 5261.59% of all US stocks.
- QURE has a lower variance in analysts' estimates than -4869.67% of all US stocks.
- In terms of how UNIQURE NV fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 4904.09% of that group.
- In terms of how UNIQURE NV fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 3832.53% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to UNIQURE NV are XNCR, PAHC, and SAGE.
View All Top Stocks by Price Target
Make investment decisions regarding QURE using the data that counts. Try POWR Ratings for free.